Fyrfly Venture Partners

Fyrfly Venture Partners is a venture capital firm established in 2015 and based in Menlo Park, California. The firm specializes in investing in startups and early-stage companies, primarily within the information technology sector. Fyrfly Venture Partners emphasizes opportunities related to data and intelligence, seeking innovative solutions and technologies that can drive growth in this rapidly evolving field.

Francis Krauch

Associate

Julie Maples

General Partner

Wintermute, Mary

CFO

Past deals in Switzerland

Altoida

Series A in 2022
Altoida AG, founded in 2016 and headquartered in Lucerne, Switzerland, specializes in developing innovative healthcare solutions for Alzheimer's patients. The company has created a platform that transforms the assessment of brain function and the diagnosis of neurological diseases through the use of smartphones and tablets. Their flagship product, a Computerized Cognitive Assessment Aid, has received FDA Breakthrough Device Designation, reflecting its potential to significantly improve patient outcomes. Altoida's approach is grounded in over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence, employing machine-learning algorithms to evaluate cognitive and functional performance. The platform aims to enable healthcare professionals to detect Alzheimer's and dementia at an early stage, providing critical insights that can inform treatment strategies.

Unique

Seed Round in 2021
Founded in 2021 in Zurich, Switzerland, by Swiss entrepreneurs Manuel Grenacher (CEO) and Andreas Hauri (CTO), Unique is a venture-backed B2B SaaS platform that records client conversations and leverages the power of AI to augment client-facing teams with real-time assistance and post-recording insights to build better client relationships and automate routine tasks. Unique cuts out manual work for client advisors by automatically generating a call summary and updating their CRM systems. During client meetings, it identifies key phrases (pain points, product mentions, etc.) to help advisors spot new upselling and cross-selling opportunities.

Locatee

Series A in 2020
Locatee AG is a Zurich-based company that specializes in workplace analytics solutions aimed at optimizing office space utilization. Founded in 2014, Locatee provides an innovative analytics platform that measures office occupancy without the need for hardware, allowing for both temporary and permanent assessments of space usage. By processing data from various sources through its patented technology, Locatee transforms complex information into clear insights, enabling corporate leaders and managers to make informed decisions about their real estate. The platform visualizes occupancy data effectively, helping organizations identify opportunities for optimization, realize cost savings, and improve the overall workplace experience across their portfolios.

Altoida

Series A in 2019
Altoida AG, founded in 2016 and headquartered in Lucerne, Switzerland, specializes in developing innovative healthcare solutions for Alzheimer's patients. The company has created a platform that transforms the assessment of brain function and the diagnosis of neurological diseases through the use of smartphones and tablets. Their flagship product, a Computerized Cognitive Assessment Aid, has received FDA Breakthrough Device Designation, reflecting its potential to significantly improve patient outcomes. Altoida's approach is grounded in over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence, employing machine-learning algorithms to evaluate cognitive and functional performance. The platform aims to enable healthcare professionals to detect Alzheimer's and dementia at an early stage, providing critical insights that can inform treatment strategies.

Altoida

Convertible Note in 2018
Altoida AG, founded in 2016 and headquartered in Lucerne, Switzerland, specializes in developing innovative healthcare solutions for Alzheimer's patients. The company has created a platform that transforms the assessment of brain function and the diagnosis of neurological diseases through the use of smartphones and tablets. Their flagship product, a Computerized Cognitive Assessment Aid, has received FDA Breakthrough Device Designation, reflecting its potential to significantly improve patient outcomes. Altoida's approach is grounded in over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence, employing machine-learning algorithms to evaluate cognitive and functional performance. The platform aims to enable healthcare professionals to detect Alzheimer's and dementia at an early stage, providing critical insights that can inform treatment strategies.

Piavita

Series A in 2018
Piavita AG, founded in 2016 and headquartered in Zurich, Switzerland, specializes in developing advanced technology for the veterinary industry. The company has created a compact, matchbox-sized wearable device that accurately measures vital medical data from pets, including horses, without the need for clipping fur or extensive preparation. This innovative system is complemented by a web-based application that enables real-time monitoring and historical tracking of vital signs, improving the diagnostic capabilities available to veterinarians. By providing reliable insights into pet health and facilitating better communication between pet owners and veterinary professionals, Piavita aims to lead the digital transformation of veterinary care, addressing the gaps in current veterinary practices and enhancing the overall wellbeing of animals.

Altoida

Seed Round in 2016
Altoida AG, founded in 2016 and headquartered in Lucerne, Switzerland, specializes in developing innovative healthcare solutions for Alzheimer's patients. The company has created a platform that transforms the assessment of brain function and the diagnosis of neurological diseases through the use of smartphones and tablets. Their flagship product, a Computerized Cognitive Assessment Aid, has received FDA Breakthrough Device Designation, reflecting its potential to significantly improve patient outcomes. Altoida's approach is grounded in over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence, employing machine-learning algorithms to evaluate cognitive and functional performance. The platform aims to enable healthcare professionals to detect Alzheimer's and dementia at an early stage, providing critical insights that can inform treatment strategies.

Locatee

Locatee AG is a Zurich-based company that specializes in workplace analytics solutions aimed at optimizing office space utilization. Founded in 2014, Locatee provides an innovative analytics platform that measures office occupancy without the need for hardware, allowing for both temporary and permanent assessments of space usage. By processing data from various sources through its patented technology, Locatee transforms complex information into clear insights, enabling corporate leaders and managers to make informed decisions about their real estate. The platform visualizes occupancy data effectively, helping organizations identify opportunities for optimization, realize cost savings, and improve the overall workplace experience across their portfolios.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.